Arch Venture Fund VII LP bought $5.0M of Syros Pharmaceuticals, Inc.

10% owner

Bought$5,000,000

$12.50Price

400,000Shares

+9%Stake

What SYRS did for a copier

Prices for SYRS after this filing aren't in yet.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Wed, Jul 6. Filed Thu, Jul 7. Not investment advice.